XORTX Therapeutics Inc. (XRTX)
NASDAQ: XRTX · IEX Real-Time Price · USD
3.700
+0.120 (3.35%)
Mar 28, 2024, 4:00 PM EDT - Market closed

XORTX Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2022202120202019
Net Income
-9.49-1.65-1.28-0.63
Depreciation & Amortization
0.080.020.020.02
Share-Based Compensation
0.630.50.290.03
Other Operating Activities
-3.19-4.930.240.33
Operating Cash Flow
-11.97-6.06-0.73-0.25
Capital Expenditures
-0.03000
Other Investing Activities
-0.03-0.04-0.01-0.01
Investing Cash Flow
-0.06-0.04-0.01-0.01
Share Issuance / Repurchase
6.8622.880.90
Debt Issued / Paid
-0.06000
Other Financing Activities
-0.371.57-0.040.06
Financing Cash Flow
6.4324.460.860.06
Exchange Rate Effect
0.870.3300
Net Cash Flow
-4.7318.680.11-0.2
Free Cash Flow
-11.99-6.06-0.73-0.25
Free Cash Flow Per Share
-8.11-5.54-0.98-0.42
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).